Sigma Planning Corp Exelixis, Inc. Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$15.87 - $22.4 $257,046 - $362,812	-16,197 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$18.56 - $22.45 $300,616 - $363,622	16,197 New	16,197 $349,000
Q1 2018 May 11, 2018	SELL	$22.15 - $31.89 $151,506 - $218,127	-6,840 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$24.23 - $30.93 $165,733 - $211,561	6,840	6,840 $208,000

498

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.